TY  - JOUR
AU  - Reviejo, Maria
AU  - Soto, Meraris
AU  - Lozano, Elisa
AU  - Asensio, Maitane
AU  - Martínez-Augustin, Olga
AU  - Sánchez de Medina, Fermín
AU  - Marin, Jose J G
PY  - 2021
DO  - 10.1016/j.bcp.2021.114810
UR  - https://hdl.handle.net/10668/25027
T2  - Biochemical pharmacology
AB  - A shared characteristic of many tumors is the lack of response to anticancer drugs. Multiple mechanisms of pharmacoresistance (MPRs) are involved in permitting cancer cells to overcome the effect of these agents. Pharmacoresistance can be primary...
LA  - en
KW  - Alternative splicing
KW  - Chemoresistance
KW  - Chemotherapy
KW  - Pharmacoresistance
KW  - Spliceosome
KW  - Tumor
KW  - Alternative Splicing
KW  - Animals
KW  - Antineoplastic Agents
KW  - Drug Resistance, Neoplasm
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Neoplasms
TI  - Impact of alternative splicing on mechanisms of resistance to anticancer drugs.
TY  - research article
VL  - 193
ER  -